1. Home
  2. MOLN vs ATLO Comparison

MOLN vs ATLO Comparison

Compare MOLN & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • ATLO
  • Stock Information
  • Founded
  • MOLN 2004
  • ATLO 1903
  • Country
  • MOLN Switzerland
  • ATLO United States
  • Employees
  • MOLN N/A
  • ATLO N/A
  • Industry
  • MOLN
  • ATLO Major Banks
  • Sector
  • MOLN
  • ATLO Finance
  • Exchange
  • MOLN Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • MOLN 183.2M
  • ATLO 166.6M
  • IPO Year
  • MOLN 2021
  • ATLO N/A
  • Fundamental
  • Price
  • MOLN $4.68
  • ATLO $18.29
  • Analyst Decision
  • MOLN
  • ATLO
  • Analyst Count
  • MOLN 0
  • ATLO 0
  • Target Price
  • MOLN N/A
  • ATLO N/A
  • AVG Volume (30 Days)
  • MOLN 2.1K
  • ATLO 15.8K
  • Earning Date
  • MOLN 03-13-2025
  • ATLO 01-24-2025
  • Dividend Yield
  • MOLN N/A
  • ATLO 4.37%
  • EPS Growth
  • MOLN N/A
  • ATLO N/A
  • EPS
  • MOLN N/A
  • ATLO 1.14
  • Revenue
  • MOLN $7,105,397.00
  • ATLO $54,221,000.00
  • Revenue This Year
  • MOLN N/A
  • ATLO N/A
  • Revenue Next Year
  • MOLN N/A
  • ATLO N/A
  • P/E Ratio
  • MOLN N/A
  • ATLO $16.04
  • Revenue Growth
  • MOLN N/A
  • ATLO 3.70
  • 52 Week Low
  • MOLN $3.32
  • ATLO $15.69
  • 52 Week High
  • MOLN $12.70
  • ATLO $22.03
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 35.14
  • ATLO 56.73
  • Support Level
  • MOLN $4.78
  • ATLO $18.24
  • Resistance Level
  • MOLN $4.96
  • ATLO $18.62
  • Average True Range (ATR)
  • MOLN 0.08
  • ATLO 0.32
  • MACD
  • MOLN -0.02
  • ATLO -0.03
  • Stochastic Oscillator
  • MOLN 0.00
  • ATLO 78.85

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.

Share on Social Networks: